Background: Shigella species are an important cause of diarrhea in developing countries. These bacteria normally acquire their antibiotic resistance via several different mobile genetic elements including plasmids, transposons, and integrons involving gene cassettes. During a diarrhea surveillance study in Thimphu, Bhutan in June and July, 2011, Shigella sonnei were isolated more frequently than expected. This study describes the antibiotic resistance of these S. sonnei isolates. Methods: A total of 29 S. sonnei isolates from Thimphu, Bhutan was characterized for antimicrobial susceptibility by disc diffusion assay and minimum inhibitory concentration (MIC) assay. All isolates were tested by pulsed-field gel electrophoresis (PFGE) with restriction enzyme XbaI and were tested for plasmid. The plasmid patterns and the PFGE patterns were analyzed by Bionumerics software. DNA sequencing was performed on amplified products for gyraseA gene and class 1 and class 2 integrons. S. sonnei isolates were classified for incompatibility of plasmids by PCR-based replicon typing (PBRT). Results: These S. sonnei were resistant to multiple drugs like ciprofloxacin, nalidixic acid, trimethoprim-sulfamethoxazole, streptomycin, and tetracycline but susceptible to azithromycin. All isolates had class 2 integrons dfrA1, sat1 and aadA1 genes. Two point mutations in Gyrase A subunit at position Ser83Leu and Asp87Gly were detected in these quinolone resistant isolates. The plasmid and PFGE patterns of S. sonnei isolates suggested a clonal relationship of the isolates. All isolates carried common ColE plasmid. ColE plasmid co-resided with B/O plasmid (nine isolates) or I1 plasmid (one isolate). Conclusions: The characteristics of 29 S. sonnei isolates from Thimphu, Bhutan in June and July, 2011 are identical in PFGE, plasmid and resistance pattern. This study suggests that these recent S. sonnei isolates are clonally related and multidrug-resistant.
Background
Shigella species are an important cause of diarrhea in developing countries. In 2013, the World Health Organization (WHO) reported the diarrheal disease is a leading cause of child mortality and morbidity in the world, and mostly results from contaminated food and water sources. Worldwide, 780 million individuals lack access to improved drinking-water and 2.5 billion lack improved sanitation. Diarrhea due to infection is widespread throughout developing countries. Globally, there are nearly 1.7 billion cases of diarrheal disease every year. Each year diarrhea kills around 760, 000 children under five years of age [1] . Bhutan is a developing country in the South Asia region with decent health care access throughout the country. The current population of the country is around 706,800 with about 80% of the population residing in rural areas. Children under 5 years of age comprise about 10% of the total population with an annual birth cohort of 14,000 [2] . For Bhutan, diarrheal disease is an important public health problem. Treatment for diarrheal disease in the country is empirical rather than evidence based due to the lack of diarrhea etiology data. In the Annual Health Bulletin, Bhutan reported an average of 60,000-70,000 cases of diarrhea and 25,000-30,000 cases of dysentery per year from [2005] [2006] [2007] [2008] [2009] . The overall incidence of diarrheal diseases in Bhutan during 2010 was 126.6 per 1,000 people. The percentage of diarrhea and dysentery that occurred in children less than 5 years of age for 2009 were 34% and 30%, respectively [3] . Shigellosis has been a notifiable disease in Bhutan since May 2010 with only one case reported [4] . In 2011, a reported diarrhea outbreak probably caused by Shigella flexneri occurred during March 2011 in a remote village in Mongar District, Bhutan [5] . During a diarrhea surveillance study in Thimphu, Bhutan from March 2011 to February 2013, Shigella sonnei was isolated from children's stool samples more frequently than expected in June and July 2011.
The rapid emergence of multidrug-resistant (MDR) strains is largely due to their ability to acquire and disseminate exogenous genes associated with mobile genetic elements such as, transposons, integrons, plasmids, and genomic islands [6] . Some transposons code for single resistance [e.g. TEM b-lactamase (Tn3), kanamycin (Tn5) and tetracycline resistance (Tn10)], but plasmids and transposons coding multiple drug resistance often possess another genetic element, the integron [7] . Integrons are genetic elements that contain the components of a site-specific recombination system that recognizes and captures mobile gene cassettes. Based on the characteristics of their integrase genes, four classes of integrons (classes 1, 2, 3, and 4) have been identified to date [8] . Class 1 and 2 integrons have been frequently reported in studies of human Shigella [9] . Antibiotic-resistance plasmids frequently contain genes conferring resistance to several different antibiotics. The ability to recognize and categorize plasmids in homogeneous groups on the basis of their phylogenetic relatedness can be helpful to analyze their distribution in nature, the relationship with the host cell and to discover their evolutionary origin [10] .
To further study the multidrug resistance in Thimphu, Bhutan, we characterized S. sonnei isolates from children, the genetic basis of antibiotic resistance including class 1 and class 2 integrons, DNA gyrase A mutations and plasmid replicon typing.
Methods

Clinical specimens
A diarrhea etiology study was conducted at Jigme Dorji Wangchuk National Referral Hospital (JDWNRH) in Thimphu, Bhutan from March 2011 to February 2013. Children 3 months to 5 years of age presenting for clinical care at JDWNRH with a chief complaint of acute diarrhea (3 or more loose stools in the previous 24 hours starting no more than 72 hours before presenting were eligible to provide a stool sample as cases. Children 3 months to 5 years presenting for clinical care at JDWNRH for other causes, who not had a history of diarrhea in the past 2 weeks and had not received antibiotics in the past 3 days were eligible to provide stool samples as controls. The study was approved by the Research Ethics Board of Health (REBH), Bhutan and the Institutional Review Board (IRB), Walter Reed Army Institute of Research (WRAIR). Stool samples were collected from children with verbal informed consent from their parent or guardian.
Specimen processing and identification
Stool samples collected in Cary-Blair transport medium were cultured on MacConkey (MAC) and Hektoen Enteric (HE) agar (Becton-Dickinson and Company, Sparks, MD, USA) and subsequently incubated at 37°C overnight. Plates are examined for the presence of colonies resemble to Shigella and identified by standard biochemical tests and further serotyped by agglutination test (Denka Seiken, Japan) at the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand [11] . Isolates were stored in Luria-Bertani (LB) broth containing 15% glycerol at −70°C until use.
Antimicrobial susceptibility methods
The S. sonnei isolates were tested for susceptibility to antimicrobial agents by the standard disk diffusion method according to Clinical and Laboratory Standards Institute (CLSI) guideline [12] . Antimicrobial disks included azithromycin (AZM 15 μg), nalidixic acid (NA 30 μg), ciprofloxacin (CIP 5 μg), ampicillin (AM 10 μg), trimethoprim-sulfamethoxazole (SXT 1.25/23.75 μg), ceftriaxone (CRO 30 μg), streptomycin (S 10 μg), and tetracycline (TE 30 μg) (Sensi-Disc; Becton Dickinson, NJ, USA). Minimum inhibitory concentrations (MIC) for AZM, NA, and CIP were also determined by E-test (AB Biodisk, Solna, Sweden). The standard disk diffusion method and MIC were interpreted according to CLSI guideline [12] . Organisms used for quality control of antimicrobial susceptibility testing included Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, and Staphylococcus aureus ATCC 29213. In the absence of CLSI definitive standards for azithromycin (AZM) breakpoints of the family Enterobacteriaceae, interpretive standards as published by the disk manufacturer for Staphylococcus spp. was used (BBL package insert; Becton-Dickinson and Company, Sparks, MD, USA). Multidrug-resistant (MDR) S. sonnei strains were defined as strains that were resistant to two or more antimicrobial agents.
Pulsed-field gel electrophoresis (PFGE)
Pulsed-field gel electrophoresis (PFGE) was performed according to the One-Day (24-28 h) Standardized Laboratory Protocol for Molecular Subtyping by PFGE [13] with minor modifications. The cell density of each isolate was adjusted by spectrophotometer (Bio-Rad, Hercules, CA, USA). Plug slices of samples and Salmonella Braenderup H9812 universal size standard were prepared for XbaI digestion and loaded on 1% SeaKem Gold agarose (Lonza, Rockland, ME, USA) with 0.5x TBE pH 8.3 (890 mM Tris, 890 mM Borate, 20 mM EDTA). The gel was electrophoresed by CHEF Mapper system (Bio-Rad, Hercules, CA, USA). The electrophoresis conditions for XbaI digestion were auto algorithm mode, 30-600 kb for molecular weight range, and 19 h for run time. The gel images were captured by a gel documentation system (Syngene, Cambridge, UK). Combined dendrogram of PFGE and antimicrobial susceptibility were generated by BioNumerics Software version 6.0 (Applied Maths, Kortrijk, Belgium), UPGMA (Unweighted Pair Group Method with Arithmetic Mean) type and Dice coefficient with 1.0% optimization and tolerance.
Plasmid analysis
The S. sonnei isolates, E. coli V.517 and E. coli 39R were grown in 5 ml LB broth at 200 rpm, 37°C overnight. Plasmid DNAs were extracted by alkaline lysis method [14] and separated by electrophoresis on a 0.8% agarose gel with 0.5x TBE using plasmids from E. coli V.517 and E. coli 39R as reference size markers. A combined dendrogram of plasmid and antimicrobial susceptibility were generated by BioNumerics Software version 6.0 (Applied Maths, Kortrijk, Belgium), UPGMA type and Dice coefficient with 1.5% optimization and tolerance.
Multiplex PCR for plasmid replicon typing
The S. sonnei isolates were examined by PCR using three multiplex primer panels for the presence of 18 replicon plasmids and three singleplex primer pairs for an additional 3 replicon plasmids, ColE, IncU and IncR plasmids (Table 1) . S. sonnei isolates and reference plasmids for controls were grown on TSA plates at 37°C overnight and were extracted for genomic DNA using DNeasy Blood and Tissue Kit (QIAGEN, Valencia, CA, USA). The reference plasmid controls were kindly provided by Dr. Alessandra Carottoli. PCR reactions were performed as previously described [15, 16] . Positive controls as well as a negative control without DNA were run with each multiplex primer panel.
Amplification of Integrons, DNA gyrase A gene and azithromycin resistance gene (mphA)
The S. sonnei isolates were grown on TSA plates at 37°C overnight and purified for genomic DNA extracted using DNeasy Blood and Tissue Kit (QIAGEN, Valencia, CA, USA). DNA templates were kept at −20°C before use. Extracted DNA was amplified for class 1 and class 2 integrons, DNA gyrase A gene and azithromycin resistance gene (mphA) by PCR (Table 1) , as previously described [17] [18] [19] .
Restriction fragment length polymorphism (RFLP)
RFLP was performed on amplified DNA of class 2 integrons of the S. sonnei isolates by using Int2CaF and Int2CaR primers (Table 1) and PCR conditions as previously described [17] . Amplified product was purified by Wizard® SV Gel and PCR Clean-Up System (Promega, Madison, WI, USA) and digested with XbaI (Roche, Indianapolis, IN, USA) at 37°C for 2 hours. The restriction fragments were detected on a 1.5% agarose gel by electrophoresis with 0.5X TBE buffer. Two-log DNA ladder (BioLabs, Ipswich, MA, USA) was used as a standard DNA marker.
Sequencing and bioinformatics analysis
The amplified PCR products of S. sonnei isolates, class 1 integrons, class 2 integrons and the gyrase A gene were purified by Wizard® SV Gel and PCR Clean-Up System and were sequenced (Macrogen, Korea). The nucleotide sequences were analyzed with BLAST software (www. ncbi.nlm.nih.gov/BLAST). 
Results
Shigella sonnei isolates
Multidrug-resistant Shigella sonnei in Bhutan
In this study, the 29 S. sonnei isolates from Thimphu, Bhutan were resistant to NA, CIP, SXT, S and TE by disk diffusion assay (Table 2 ). These 29 isolates had an MIC of NA (>256 μg/ml) and CIP (3.0-4.0 μg/ml) by E-test confirming the resistance described by disk diffusion assay. All 29 isolates were susceptible to AZM by disk diffusion assay. The MIC range of AZM by E-test was 3.0-4.0 μg/ml corresponding to intermediate susceptibility to AZM (Table 2) .
PFGE patterns and plasmid patterns analysis
At 80% similarity, the PFGE patterns of all 38 isolates clustered into 4 groups (Figure 2 ). Groups 1, 3 and 4 included S. sonnei from Nepal and Thailand. Group 2 consisted of the 29 S. sonnei isolates from Bhutan and 1 isolate from Nepal. S. sonnei isolates from Bhutan were closely related within the subgroup with 97-100% similarity. All 30 isolates in group 2 had a pattern of resistance to NA, CIP, SXT, S and TE (Figure 2 
Replicon typing
S. sonnei isolates were classified for plasmid incompatibility by PCR-based replicon typing (PBRT) with 21 primer pairs (Table 2) .
PCR and sequencing analysis
The gyrA genes of the 38 S. sonnei isolates from Bhutan, Nepal and Thailand were amplified. The sequence analysis of the 470 bp amplified products from 29 S. sonnei isolates from Bhutan and one isolate from Nepal revealed the presence of two point mutations in the GyrA subunit (Ser83Leu and Asp87Gly) ( Table 2 ). However, no amplified products were observed for the mphA gene in all 38 S. sonnei isolates compared to an azithromycin resistant Enteroaggregative E. coli control. All 38 S. sonnei isolates had amplified products of class 1 integrons of approximately 700 bp. By DNA sequencing, the amplified products of 5 selected S. sonnei isolates from Bhutan showed no homologies to published gene cassettes of class 1 integrons but had 99% identity of conserved hypothetical protein S. sonnei Ss046 in the NCBI database. Thus, S. sonnei in Bhutan did not contain resistance genes in class 1 integrons. The class 2 integrons of 38 S. sonnei isolates were also amplified. The amplified products of 29 isolates from Bhutan and 3 isolates from Nepal were of similar size (2.4 Kb) but differed from the class 2 integrons in the 3 Thailand isolates (~3-4 Kb). The DNA sequence alignment of class 2 integrons from 5 selected S. sonnei isolates from Bhutan had homology to dihydrofolate reductase (dfrA1), streptothricin acetyltransferase (sat1) and aminiglycoside adenyltransferase (aadA1) associated with resistance to trimethoprim, streptothricin and streptomycin/ spectinomycin, respectively. Moreover, RFLP of amplified products of the class 2 integrons in all 38 isolates with XbaI, yielded the same DNA restricted-fragments of approximately 1,600 bp and 800 bp in 29 S. sonnei isolates from Bhutan and 1 isolate from Nepal. The other Nepal and Thailand isolates had uncut DNA or undetectable bands.
Discussion
Over the last few years, MDR patterns in Shigella spp. have been reported in many countries [20] . In this study, all S. sonnei isolates from children in Thimphu, Bhutan in June and July, 2011 were resistant to multiple drugs like ciprofloxacin, nalidixic acid, trimethoprim-sulfamethoxazole, streptomycin and tetracycline. The MDR patterns of the S. sonnei from Bhutan differed from neighboring countries. In India, antimicrobial resistance in S. sonnei is more common than in other enteric bacteria with resistant to azithromycin, ciprofloxacin, furazolidone, nalidixic acid, norfloxacin, ofloxacin, trimethoprim-sulfamethoxazole, tetracycline [21] . In Bangladesh, most of S. sonnei isolates were resistant to nalidixic acid, sulfamethoxazoletrimethoprim, ampicillin, streptomycin and tetracycline [22] . In China, the antimicrobial resistance profiles of S. sonnei were nalidixic acid, piperacilline and ciprofloxacin [23] . In Nepal, S. sonnei isolates were resistant to azithromycin, ciprofloxacin, ceftriaxone, ampicillin, nalidixic acid and trimethoprim-sulfamethoxazole [24] .
Shigellae usually harbor various plasmids, such as those required for bacterial invasion into the host intestinal epithelial cells and antibiotic resistance, which may range in number from two to as many as ten in one strain [25] . The PFGE and plasmid patterns of S. sonnei from Thimphu, Bhutan suggested clonality. S. sonnei in Thimphu, Bhutan carried the typical number of variable plasmid sizes from 0.35 Kb to 98 Kb. These S. sonnei also contained the typical number of plasmids from seven to [28] . Previous studies reported on the frequent incidence of class 2 integrons in Shigella isolates worldwide. DNA sequencing of the class 2 integrons in this study showed homologies with class 2 integrons but no homologies to published gene cassettes of class 1 integrons. In this study, Figure 2 Dendrogram obtained by cluster analysis of the PFGE patterns of S. sonnei from Bhutan, Nepal and Thailand combined with antibiotic susceptibility. AZM, azithromycin; NA, nalidixic acid; CIP, ciprofloxacin; AM, ampicillin; SXT, trimethoprim-sulfamethoxazole; CRO, ceftriaxone; S, Streptomycin; TE, tetracycline; S, susceptible; R, resistant; ND, not determined.
S. sonnei from Thimphu, Bhutan carried three classic gene cassettes (2,433 bp) in transposon Tn7 corresponding to previous results. S. sonnei isolates from Korea carried class 2 integrons (2,224 bp) that consist of Tn7 with dfrA1, sat1 and aadA1 [29] . In Japan, two types of class 2 integrons in S. sonnei isolates were previously identified. One was the classical type (2,158 bp) with dfrA1, sat1 and aadA1. The other type was shorter (1,313 bp) and carried only two gene cassettes with dfrA1 and sat1 [20] . In China, a 3,361 bp DNA fragment was found in S. sonnei with gene cassette arrays in this class 2 integrons of dfrA1, sat1, aadA1 and orfX [17] .
Nalidixic acid resistance among enteric bacteria is related to the presence of a single amino-acid substitution at either position 83 or position 87 of GyrA, while resistance to ciprofloxacin is related to the presence of at least one additional substitution in GyrA [30] . In this study, S. sonnei in Thimphu, Bhutan presented two mutations at position 83 (Serine to Leucine) and position 87 (Aspartic acid to Glycine) related to NA and CIP resistance. These two mutations conferred extremely high resistance to NA in S. sonnei in Bhutan that has been reported previously from S. sonnei isolates in Japan [31] . The expression of mphA gene is related to the decrease of AZM susceptibility [19] . In the USA, isolates with a susceptibility at 8 mg/L lacked mphA gene but isolates with higher MICs (>64 mg/L) to AZM reportedly contained a plasmid-encoded mphA gene [19] . In this study, MIC range of AZM was 3.0-4.0 μg/ml and PCR results showed that mphA gene was not present.
Conclusions
This study described the recent antimicrobial resistance among S. sonnei strains isolated from Thimphu, Bhutan in June and July, 2011 and molecular characterization of these S. sonnei. Plasmid patterns, PFGE and uniform MDR suggest that these 29 S. sonnei isolates are closely related. All S. sonnei isolates carried common ColE plasmid that co-resided with B/O or I1 plasmid in many isolates. Further study and comparison with other isolates from the region may provide information on the development and continued spread of antibiotic resistance in S. sonnei.
